Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sephira Ryman

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Progress in Brain Research|March 6, 2022
Cognitive control in Parkinson's diseaseJames F Cavanagh, Sephira Ryman, Sarah Pirio Richardson
Journal of Neurology|November 10, 2022
Microbiome-gut-brain dysfunction in prodromal and symptomatic Lewy body diseasesSephira Ryman, Andrei A Vakhtin, Sarah Pirio Richardson, et al.
Brain Communications|November 13, 2023
Lesion network mapping of eye-opening apraxiaPardis Zarifkar, Nicholas A Shaff, Vardan Nersesjan, et al.
Frontiers in Neuroscience|January 5, 2026
Sulfate reducing bacteria induce α-synuclein in intestinal and neuronal cells and tissues and inhibit tyrosine hydroxylase in neuronal cellsSudha B Singh, Arianne J Capacio, Cody A Braun, et al.
The Journal of ECT|May 25, 2022
Ictal Theta Power as an Electroconvulsive Therapy Safety Biomarker: A Pilot StudyJeremy Miller, Tom Jones, Joel Upston, et al.
Nature Communications|March 12, 2025
Dopaminergic modulation and dosage effects on brain state dynamics and working memory component processes in Parkinson's diseaseByeongwook Lee, Christina B Young, Weidong Cai, et al.
Progress in Neurobiology|October 10, 2021
Latent brain state dynamics and cognitive flexibility in older adultsByeongwook Lee, Weidong Cai, Christina B Young, et al.
Brain : a Journal of Neurology|March 31, 2022
Dopaminergic medication normalizes aberrant cognitive control circuit signalling in Parkinson's diseaseWeidong Cai, Christina B Young, Rui Yuan, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 20, 2024
Subthalamic nucleus-language network connectivity predicts dopaminergic modulation of speech function in Parkinson's diseaseWeidong Cai, Christina B Young, Rui Yuan, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|February 2, 2026
Considerations for disclosing Alzheimer's disease risk and biomarker results in a Pueblo community in Southwest United StatesSephira Ryman, Katherine Edwards, Tamar Ginossar, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Progress in Brain Research|March 6, 2022
Cognitive control in Parkinson's diseaseJames F Cavanagh, Sephira Ryman, Sarah Pirio Richardson
Journal of Neurology|November 10, 2022
Microbiome-gut-brain dysfunction in prodromal and symptomatic Lewy body diseasesSephira Ryman, Andrei A Vakhtin, Sarah Pirio Richardson, et al.
Brain Communications|November 13, 2023
Lesion network mapping of eye-opening apraxiaPardis Zarifkar, Nicholas A Shaff, Vardan Nersesjan, et al.
Frontiers in Neuroscience|January 5, 2026
Sulfate reducing bacteria induce α-synuclein in intestinal and neuronal cells and tissues and inhibit tyrosine hydroxylase in neuronal cellsSudha B Singh, Arianne J Capacio, Cody A Braun, et al.
The Journal of ECT|May 25, 2022
Ictal Theta Power as an Electroconvulsive Therapy Safety Biomarker: A Pilot StudyJeremy Miller, Tom Jones, Joel Upston, et al.
Nature Communications|March 12, 2025
Dopaminergic modulation and dosage effects on brain state dynamics and working memory component processes in Parkinson's diseaseByeongwook Lee, Christina B Young, Weidong Cai, et al.
Progress in Neurobiology|October 10, 2021
Latent brain state dynamics and cognitive flexibility in older adultsByeongwook Lee, Weidong Cai, Christina B Young, et al.
Brain : a Journal of Neurology|March 31, 2022
Dopaminergic medication normalizes aberrant cognitive control circuit signalling in Parkinson's diseaseWeidong Cai, Christina B Young, Rui Yuan, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 20, 2024
Subthalamic nucleus-language network connectivity predicts dopaminergic modulation of speech function in Parkinson's diseaseWeidong Cai, Christina B Young, Rui Yuan, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|February 2, 2026
Considerations for disclosing Alzheimer's disease risk and biomarker results in a Pueblo community in Southwest United StatesSephira Ryman, Katherine Edwards, Tamar Ginossar, et al.
Pageof 2